Pfizer Says Third COVID Vaccine Dose Effective Against Omicron Variant
A new study by Pfizer-BioNTech found that a third dose of their COVID-19 vaccine is effective against the emerging omicron variant. The pharmaceutical giants also look to manufacture a vaccine specific to the omicron variant by March 2022.
Flexicon's resistance band system brings gym-level results without joint strain, while Pathogenix.ai's smart air monitor detects invisible threats in minutes.
Rebecca Bellan, Senior Reporter at TechCrunch, dives into ChatGPT’s GPT‑5 release—what’s new, what’s controversial, and why this model could change the game.
Meridith McGraw, White House Reporter at The Wall Street Journal, breaks down Trump’s $200M ballroom plan, D.C. police tensions, and the future of MAGA.
